ASCO 2024: Advanced Sequencing and Targeted Therapy Strategies in Renal Cell Carcinoma: How Can We Help More Patients Not at the Expense of Toxicity?
ASCO 2024 diagnostic and therapeutic strategies in renal cell carcinoma (RCC), vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs).